Distinct and Overlapping Sarcoma Subtypes Initiated from Muscle Stem and Progenitor Cells

Cell Reports

Volumn 5, Issue 4, 2013, Pages 933-940

  Blum, Jordan M ^a,b   Añó, Leonor ^a,b   Li, Zhizhong ^a   VanMater, David ^a   Bennett, Brian D ^a,b   Sachdeva, Mohit ^a   Lagutina, Irina ^c   Zhang, Minsi ^a,b   Mito, Jeffrey K ^a,b   Dodd, Leslie G ^d   Cardona, Diana M ^a   Dodd, Rebecca D ^a   Williams, Nerissa ^a   Ma, Yan ^a   Lepper, Christoph ^e   Linardic, Corinne M ^a   Mukherjee, Sayan ^b,f   Grosveld, Gerard C ^c   Fan, Chen Ming ^e   Kirsch, David G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e GEOPHYSICAL LABORATORY   (United States)

^f Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOD PROTEIN; TRANSCRIPTION FACTOR PAX7;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; IN VIVO STUDY; MOUSE; MUSCLE STEM CELL; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; STEM CELL; TUMOR SUPPRESSOR GENE; UNDIFFERENTIATED PLEOMORPHIC SARCOMA;

MUS;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE DEVELOPMENT; MYOBLASTS, SKELETAL; MYOD PROTEIN; NEOPLASTIC STEM CELLS; PAX7 TRANSCRIPTION FACTOR; PROTO-ONCOGENE PROTEINS P21(RAS); RHABDOMYOSARCOMA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84888436141     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.10.020     Document Type: Article

References (32)

1. Arndt C.A., Crist W.M. Common musculoskeletal tumors of childhood and adolescence. N.Engl. J. Med. 1999, 341:342-352.
2. Baird K., Davis S., Antonescu C.R., Harper U.L., Walker R.L., Chen Y., Glatfelter A.A., Duray P.H., Meltzer P.S. Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res. 2005, 65:9226-9235.
3. Barretina J., Taylor B.S., Banerji S., Ramos A.H., Lagos-Quintana M., Decarolis P.L., Shah K., Socci N.D., Weir B.A., Ho A., et al. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat. Genet. 2010, 42:715-721.
4. Buckingham M., Relaix F. The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu. Rev. Cell Dev. Biol. 2007, 23:645-673.
5. Chakkalakal J.V., Jones K.M., Basson M.A., Brack A.S. The aged niche disrupts muscle stem cell quiescence. Nature 2012, 490:355-360.
6. Cornelison D.D., Olwin B.B., Rudnicki M.A., Wold B.J. MyoD(-/-) satellite cells in single-fiber culture are differentiation defective and MRF4 deficient. Dev. Biol. 2000, 224:122-137.
7. Felix C.A., Kappel C.C., Mitsudomi T., Nau M.M., Tsokos M., Crouch G.D., Nisen P.D., Winick N.J., Helman L.J. Frequency and diversity ofp53 mutations in childhood rhabdomyosarcoma. Cancer Res. 1992, 52:2243-2247.
8. Fletcher C.D., Gustafson P., Rydholm A., Willen H., Akerman M. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2001, 19:3045-3050.
9. Heffner C.S., Herbert Pratt C., Babiuk R.P., Sharma Y., Rockwood S.F., Donahue L.R., Eppig J.T., Murray S.A. Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource. Nature communications 2012, 3:1218.
10. Hettmer S., Wagers A.J. Muscling in: Uncovering the origins of rhabdomyosarcoma. Nat. Med. 2010, 16:171-173.
11. Kirsch D.G., Dinulescu D.M., Miller J.B., Grimm J., Santiago P.M., Young N.P., Nielsen G.P., Quade B.J., Chaber C.J., Schultz C.P., et al. A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat. Med. 2007, 13:992-997.
12. Kuang S., Chargé S.B., Seale P., Huh M., Rudnicki M.A. Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J.Cell Biol. 2006, 172:103-113.
13. Lee S.J., Huynh T.V., Lee Y.S., Sebald S.M., Wilcox-Adelman S.A., Iwamori N., Lepper C., Matzuk M.M., Fan C.M. Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway. Proc. Natl. Acad. Sci. USA 2012, 109:E2353-E2360.
14. Lee K.Y., Russell S.J., Ussar S., Boucher J., Vernochet C., Mori M.A., Smyth G., Rourk M., Cederquist C., Rosen E.D., et al. Lessons on conditional gene targeting in mouse adipose tissue. Diabetes 2013, 62:864-874.
15. Lepper C., Conway S.J., Fan C.M. Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Nature 2009, 460:627-631.
16. Linardic C.M., Downie D.L., Qualman S., Bentley R.C., Counter C.M. Genetic modeling of human rhabdomyosarcoma. Cancer Res. 2005, 65:4490-4495.
17. Martinelli S., McDowell H.P., Vigne S.D., Kokai G., Uccini S., Tartaglia M., Dominici C. RAS signaling dysregulation in human embryonal Rhabdomyosarcoma. Genes Chromosomes Cancer 2009, 48:975-982.
18. Merlino G., Helman L.J. Rhabdomyosarcoma-working out the pathways. Oncogene 1999, 18:5340-5348.
19. Meuwissen R., Linn S.C., Linnoila R.I., Zevenhoven J., Mooi W.J., Berns A. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 2003, 4:181-189.
20. Meyer W.H., Spunt S.L. Soft tissue sarcomas of childhood. Cancer Treat. Rev. 2004, 30:269-280.
21. Morotti R.A., Nicol K.K., Parham D.M., Teot L.A., Moore J., Hayes J., Meyer W., Qualman S.J. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience. Am. J. Surg. Pathol. 2006, 30:962-968. Children's Oncology Group.
22. Mulligan L.M., Matlashewski G.J., Scrable H.J., Cavenee W.K. Mechanisms of p53 loss in human sarcomas. Proc. Natl. Acad. Sci. USA 1990, 87:5863-5867.
23. Muzumdar M.D., Tasic B., Miyamichi K., Li L., Luo L. A global double-fluorescent Cre reporter mouse. Genesis 2007, 45:593-605.
24. Rubin B.P., Nishijo K., Chen H.I., Yi X., Schuetze D.P., Pal R., Prajapati S.I., Abraham J., Arenkiel B.R., Chen Q.R., et al. Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell 2011, 19:177-191.
25. Sabourin L.A., Girgis-Gabardo A., Seale P., Asakura A., Rudnicki M.A. Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. J.Cell Biol. 1999, 144:631-643.
26. Sacco A., Doyonnas R., Kraft P., Vitorovic S., Blau H.M. Self-renewal and expansion of single transplanted muscle stem cells. Nature 2008, 456:502-506.
27. Sambasivan R., Comai G., Roux I.L., Gomes D., Konge J., Dumas G., Cimper C., Tajbakhsh S. Embryonic founders of adult muscle stem cells are primed by the determination gene Mrf4. Dev Biol 2013.
28. Stratton M.R., Fisher C., Gusterson B.A., Cooper C.S. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res. 1989, 49:6324-6327.
29. Tiffin N., Williams R.D., Shipley J., Pritchard-Jones K. PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells. Br. J. Cancer 2003, 89:327-332.
30. Tsumura H., Yoshida T., Saito H., Imanaka-Yoshida K., Suzuki N. Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice. Oncogene 2006, 25:7673-7679.
31. Tuveson D.A., Shaw A.T., Willis N.A., Silver D.P., Jackson E.L., Chang S., Mercer K.L., Grochow R., Hock H., Crowley D., et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 2004, 5:375-387.
32. Zammit P.S., Heslop L., Hudon V., Rosenblatt J.D., Tajbakhsh S., Buckingham M.E., Beauchamp J.R., Partridge T.A. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp. Cell Res. 2002, 281:39-49.